EP Patent

EP3953330A1 — Nitrile-containing antiviral compounds

Assigned to Pfizer Inc · Expires 2022-02-16 · 4y expired

What this patent protects

The invention relates to compounds of Formula (I'') wherein R, R 1 , R 2 , R 3 , p, q and q' are as defined herein, pharmaceutical compositions comprising the compounds, methods of treating coronavirus infection such as COVID-19 in a patient by administering therapeutically effec…

USPTO Abstract

The invention relates to compounds of Formula (I'') wherein R, R 1 , R 2 , R 3 , p, q and q' are as defined herein, pharmaceutical compositions comprising the compounds, methods of treating coronavirus infection such as COVID-19 in a patient by administering therapeutically effective amounts of the compounds, and methods of inhibiting or preventing replication of coronaviruses such as SARS- CoV-2 with the compounds.

Drugs covered by this patent

Patent Metadata

Patent number
EP3953330A1
Jurisdiction
EP
Classification
—
Expires
2022-02-16
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.